28.92

1.94% 0.55

After Hours: 28.91 -0.01 -0.03%

Staar Surgical Co (STAA)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Staar Surgical Co stock is traded at $28.92, with a volume of 468.35K. It is up +1.94% in the last 24 hours and down -9.82% over the past month. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Previous Close:

$28.37

Open:

$28.53

24h Volume:

468.35K

Relative Volume:

0.43

Market Cap:

$1.44B

Revenue:

$290.38M

Net Income/Loss:

$-21.03M

P/E Ratio:

-67.35

EPS:

-0.4294

Net Cash Flow:

$-54.99M

1W Performance:

-3.18%

1M Performance:

-9.82%

6M Performance:

+16.61%

1Y Performance:

+70.22%

1-Day Range:

$28.52

$29.20

1-Week Range:

$28.17

$30.12

52-Week Range:

$15.59

$35.87

Staar Surgical Co Stock (STAA) Company Profile

Name

Staar Surgical Co

Sector

Healthcare (1107)

Industry

Medical Instruments & Supplies (56)

Phone

(626) 303-7902

Address

1911 WALKER AVE, MONROVIA, CA

Employee

957

Twitter

@visianicl

Next Earnings Date

2026-08-05

Latest SEC Filings

STAA's Discussions on Twitter

Compare STAA vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STAA Staar Surgical Co	28.92	1.41B	290.38M	-21.03M	-54.99M	-0.4294
ISRG Intuitive Surgical Inc	417.07	147.53B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	145.16	40.10B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	65.84	32.33B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	37.09	31.57B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	193.94	27.96B	5.54B	1.52B	1.74B	10.37

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-09-26	Upgrade	Canaccord Genuity	Hold → Buy
Feb-03-26	Initiated	Wedbush	Neutral
Jan-16-26	Resumed	Morgan Stanley	Underweight
Apr-21-25	Initiated	Wells Fargo	Equal Weight
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy
Mar-11-24	Upgrade	Stifel	Hold → Buy
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy
Dec-08-22	Initiated	Stifel	Hold
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight
Oct-13-22	Initiated	Mizuho	Buy
Apr-08-22	Initiated	Needham	Buy
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy
Jul-09-21	Initiated	Oppenheimer	Perform
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold
Oct-26-20	Downgrade	Sidoti	Buy → Neutral
Aug-31-20	Upgrade	Sidoti	Neutral → Buy
Aug-06-20	Reiterated	The Benchmark Company	Buy
Jul-06-20	Downgrade	Sidoti	Buy → Neutral
Jun-24-20	Downgrade	BTIG Research	Buy → Neutral
Jun-15-20	Initiated	Jefferies	Buy
Dec-04-19	Initiated	BTIG Research	Buy
Sep-24-18	Reiterated	The Benchmark Company	Buy
Aug-06-18	Resumed	The Benchmark Company	Buy
Nov-20-17	Reiterated	The Benchmark Company	Buy
Aug-14-17	Reiterated	The Benchmark Company	Buy
Mar-03-17	Reiterated	The Benchmark Company	Buy
May-18-16	Upgrade	The Benchmark Company	Hold → Buy
Sep-10-13	Resumed	The Benchmark Company	Buy
Feb-28-13	Reiterated	The Benchmark Company	Buy
Nov-01-12	Downgrade	Canaccord Genuity	Buy → Hold
Mar-02-12	Initiated	Northland Securities	Outperform
Oct-25-11	Reiterated	The Benchmark Company	Buy
Oct-12-10	Initiated	Morgan Joseph	Buy
May-11-10	Initiated	Benchmark	Buy

View All

Staar Surgical Co Stock (STAA) Latest News

Jun 16, 2026

STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple - simplywall.st

Jun 16, 2026

Jun 15, 2026

Director Lilian Zhou of STAAR Surgical (STAA) receives 3,530-share stock award - Stock Titan

Jun 15, 2026

Jun 12, 2026

Medical Devices & SuppliesSpecialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders - Yahoo Finance

Jun 12, 2026

Jun 10, 2026

STAAR Surgical Raises Pay for Interim Co-CEO Andrews - The Globe and Mail

Jun 10, 2026

Jun 09, 2026

STAAR appoints Deborah Andrews as Interim Co-CEO and CFO with pay increase - TradingView

Jun 09, 2026

STAAR Surgical (STAA) boosts interim co-CEO and CFO Deborah Andrews’ salary and bonus - Stock Titan

Jun 09, 2026

CenterBook Partners LP Buys New Position in STAAR Surgical Company $STAA - MarketBeat

Jun 09, 2026

Jun 05, 2026

STAA News | STAAR SURGICAL CO (NASDAQ:STAA) - ChartMill

Jun 05, 2026

Jun 04, 2026

How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets - Yahoo Finance

Jun 04, 2026

Jun 03, 2026

Midday Stock Roundup: TTM, Western Technology Up - Orange County Business Journal

Jun 03, 2026

Jun 02, 2026

STAAR Surgical Stock Hits Day Low of $29.03 Amid Price Pressure - MarketsMojo

Jun 02, 2026

Jun 01, 2026

Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors. - The Motley Fool

Jun 01, 2026

Staar Surgical Q1 Signals Potential Turnaround - Orange County Business Journal

Jun 01, 2026

May 31, 2026

STAAR Surgical Co stock (US8577001096): shares consolidate after Q1-driven jump on Nasdaq - AD HOC NEWS

May 31, 2026

May 29, 2026

STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus

May 29, 2026